ExonanoRNA Therapeutics focuses on developing first-in-class, RNA nanotechnology-based therapeutics for cancer treatment. ExonanoRNA is the leader in RNA nanotechnology, which has shown to overcome the limitations of conventional cancer therapeutics and can deliver its own therapeutics (siRNA, miRNA, and chemical drugs) to specific cancer cellswith significantly enhanced effect without any detectable toxicity or side effect.

Biotechnology

ExonanoRNA

ExonanoRNA's headquarters in Columbus, OH, United States

Description

People (1)

Hiroshi Nakanishi

Jobs